Product Information
PIPERACIL-TAZOBACT 3.375 GM VL is a generic product labeled by BluePoint Laboratories, priced at $3.4926 per EA under NDC 68001050782. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Aug 10, 2018. Its Orange Book therapeutic-equivalence code is AP.
Strength
3; .375 g/15mL; g/15mL
Manufacturer
BluePoint LaboratoriesNDC
68001050782
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
1/21/2026
Active Ingredients
PIPERACILLIN SODIUM; TAZOBACTAM SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA204959FDA Approved
8/10/2018
TE Code
AP
On Market Since
8/11/2021
Pharmacological Classes
Price Statistics
The NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has been published 116 times since Jul 17, 2024, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4926 per EA |
|---|---|
| All-time high | $4.5612 (Oct 16, 2024) |
| All-time low | $2.8072 (May 21, 2025) |
| 52-week high | $3.6157 |
| 52-week low | $3.4286 |
| Median price | $3.4926 |
| Average price | $3.5277 |
| Largest weekly change | -17.8% (Oct 23, 2024) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PIPERACILLIN and TAZOBACTAM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PIPERACIL-TAZOBACT 3.375 GM VL?
The current National Average Drug Acquisition Cost (NADAC) for PIPERACIL-TAZOBACT 3.375 GM VL, manufactured by BluePoint Laboratories, is $3.4926 per EA (NDC 68001050782), effective Sep 30, 2026.
How has the price of PIPERACIL-TAZOBACT 3.375 GM VL changed over time?
Over the history we have for it, the NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has declined 23.4%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for PIPERACIL-TAZOBACT 3.375 GM VL?
Since Jul 17, 2024, the NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has ranged from a low of $2.8072 (May 21, 2025) to a high of $4.5612 (Oct 16, 2024), with a median of $3.4926 per EA.
Are there cheaper alternatives to PIPERACIL-TAZOBACT 3.375 GM VL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PIPERACIL-TAZOBACT 3.375 GM VL in a comparable dosage form, but none are currently priced below it.
Who manufactures PIPERACIL-TAZOBACT 3.375 GM VL?
PIPERACIL-TAZOBACT 3.375 GM VL (NDC 68001050782) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.